• Home
  • About Us
  • About Dementia
  • Diagnosis Tool
  • Collaborate
  • Contact Us
  • Home
  • About Us
  • About Dementia
  • Diagnosis Tool
  • Collaborate
  • Contact Us

Your browser does not support HTML5 video.

What We Do

We are committed to having a 
low-cost, highly predictive  approach 
that gives access to 

fast dementia diagnosis 
without the need of expensive 
scans and investigations

We aid in quick dementia diagnosis
because you deserve to know early

We aid​ in quick dementia diagnosis because you deserve to know early

Cogni.Dx respects your well-being, 
pace and privacy,
that is why we offer instant, 
accurate, preliminary diagnosis of 
all cognitive and behavioural concerns, 
from the comfort of your home, 
and provide comprehensive 
care plans to help you manage 
your journey

Interested to know more?
 

Enter your email below to find out more abou​t how 
you can be a part of our global clinical validation trials 

Interested to know more?

Enter your email below to find out more abou​t how you can be a part of our global clinical validation trials 

Submit
Thank you! Your message has been sent.
Unable to send your message. Please fix errors then try again.

Our Mission

To provide early access to dementia treatment in order to maximise quality of life for patients

To enhance the patient's  experience, remove the stigma associated with dementia, and help GPs confidently diagnose it

To add quality years to people's lives by allowing them to plan for their future and work for longer through early diagnosis

To create awareness around dementia and encourage people to emerge from social isolation and feel more included in society

Early Pilot Studies

Results of our 2 pilot studies

200

Patients

157 e-histories
43 face-to-face

94%

Sensitivity

Cogni.Dx can detect 94% of the people with dementia

99%

Specificity

Cogni.Dx can detect 99% of the people with no dementia

97%

Accuracy

Cogni.Dx is 97% accurate, regardless of dementia or not 

Our Technology

Coding

  • The cognitive assessments are developed digitally using friendly visual techniques and gaming methodologies
  • With the help of decision trees and back-end logic, a preliminary dementia or MCI diagnosis is given

AI/ML

  • The ML strategies used identify the optimum data set that needs to be collected for accuracy and efficiency
  • The ML algorithm predicts the dominant questions for each subtype

Digital Weights

  • Cogni.Dx consists of questions in the medical, cognitive and behavioural history domains
  • The questions are assigned weights that reflect the presence of cognitive symptoms that are highly predictive of the clinical dementia diagnosis

Assessments

  • A performance-based cognitive assessment battery is incorporated into the tool to identify the extent of cognitive decline
  • The assessment is visually represented in a user-friendly, gamified way.

Don't wait until it's too late! 

Let your GP/Physician know about Cogni.Dx
and let's get you started on a trial

Inform
Thank you! Your message has been sent.
Unable to send your message. Please fix errors then try again.

Meet the Experts

Dr. Bushra Siddiqi, PhD

Founder & Chief Executive Officer

Health informatician with extensive experience in developing and advising on web solutions for healthcare. Developed the 1st National Alzheimer's Registry for Saudi Arabia. Specialist in the use of novel visualisation techniques like process mining for care pathway analysis.

Dr. Najeeb Qadi, MD, MBA

Chief Clinical Advisor

Cognitive & behavioural neurologist sub-specialising in Alzheimer's Disease. Has extensive experience diagnosing and treating different forms of dementia & ADHD. Associate professor of Neurology at Al-Faisal University, Riyadh. Director of the Neuroscience Centre at KFSH&RC, Riyadh, KSA.

Dr. Claudia Jacova, PhD

Clinical Advisor (USA)

Professor of Clinical Psychology at Pacific University, Oregon, USA. Has internationally recognized expertise in early manifestations of Alzheimer's Disease (AD). Is a lead author on the novel diagnostic AD framework. 

Dr. Robin Hsiung, MD

Clinical Advisor (Canada)

Associate professor of Neurology at UBC, Vancouver, Canada. Specialist in clinical & genetic epidemiology of Alzheimer's Disease. President of the Consortium of Canadian Centres for Clinical Cognitive Research (C5R).

© Cogni.Dx Ltd. 2023    
 
 Privacy Policy
| Terms of Use | Cookies Policy

Your Privacy Matters

Cogni.Dx uses cookies to​ personalise and improve your experience on our site. You can opt out of some cookies by adjusting your browser settings. By using our site, you agree to our use of cookies.

Confirm
Decline